Figure 5.
Restoration of ACAID by the transfer of WT spleen cells in δ−/− mice. B6 mice received 25 × 106 B6 spleen cells (▪) or 25 × 106 spleen cells and OVA via the anterior chamber (♦). δ−/− mice received anterior chamber treatment only (◊) or 25 × 106 B6 spleen cells before OVA via the anterior chamber (○). All mice were primed and tested for DTH as described in Figure 3.